Cat. #158064
Anti-SAA5
Cat. #: 158064
Unit size: 100 ug
Availability: 10-12 weeks
Target: Serum amyloid A-5 (SAA5)
Class: Polyclonal
Application: ELISA ; IHC ; WB
Reactivity: Salmon ; Rainbow Trout ; Salmonids
Host: Rabbit
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Abdo Alnabulsi
Institute: Vertebrate Antibodies Limited
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-SAA5
- Research fields: Cell biology;Immunology
- Class: Polyclonal
- Conjugation: Unconjugated
- Molecular weight: 11.6
- Reactivity: Salmon ; Rainbow Trout ; Salmonids
- Host: Rabbit
- Application: ELISA ; IHC ; WB
- Description: Serum amyloid A (SAA) proteins are a family of apolipoproteins associated with high-density lipoprotein (HDL) in plasma. SAA is a highly conserved, acute-phase protein (APP) synthesized predominantly by the liver. Different isoforms of SAA are expressed constitutively (constitutive SAAs, SAA 4, 5) at different levels or in response to inflammatory stimuli (acute phase SAAs, SAA 1-3). SAA also exhibits significant immunological activity by, for example, inducing the synthesis of several cytokines and by being chemotactic for neutrophils and mast cells. SAAs are reported as potential target in the treatment of diseases associated with inflammation. SAA5 is significant as it is reported as a potential target to monitor inflammation and inflammation.
- Immunogen: Ovalbumin-conjugated synthetic peptide
- Recommended controls: ELISA: peptide immunogen, recombinant protein WB: recombinant protein IHC: formalin-fixed, paraffin-embedded multi-tissue microarray
Target Details
- Target: Serum amyloid A-5 (SAA5)
- Molecular weight: 11.6
- Target background: Serum amyloid A (SAA) proteins are a family of apolipoproteins associated with high-density lipoprotein (HDL) in plasma. SAA is a highly conserved, acute-phase protein (APP) synthesized predominantly by the liver. Different isoforms of SAA are expressed constitutively (constitutive SAAs, SAA 4, 5) at different levels or in response to inflammatory stimuli (acute phase SAAs, SAA 1-3). SAA also exhibits significant immunological activity by, for example, inducing the synthesis of several cytokines and by being chemotactic for neutrophils and mast cells. SAAs are reported as potential target in the treatment of diseases associated with inflammation. SAA5 is significant as it is reported as a potential target to monitor inflammation and inflammation.
Applications
- Application: ELISA ; IHC ; WB
Handling
- Format: Liquid
- Unit size: 100 ug
- Storage buffer: Unpurified anti-serum from rabbit preserved in 0.02% Thiomersal
- Shipping conditions: Shipping at 4° C
